Literature DB >> 6979963

Reduction of the elastase inhibitory capacity of alpha 1-antitrypsin by peroxides in cigarette smoke: an analysis of brands and filters.

A B Cohen, H L James.   

Abstract

A procedure for measuring the oxidant content of aqueous condensates of tobacco cigarette smoke is described. The procedure was used in conjunction with analysis of the ability of the smoke solutions to inactivate the elastase inhibitory capacity (EIC) of alpha 1-antitrypsin. The ability of the smoke of a brand to inactivate alpha 1-antitrypsin correlates well with the known tar and nicotine and with the amount of oxidants as measured using o-dianisidine. Filters were found to remove about 73% of the oxidants from smoke. Smoke from a commercial nontobacco cigarette was also found to contain a significant amount of oxidants and to also destroy alpha 1-antitrypsin. Catalase and superoxide dismutase reduce the effect of solutions containing smoke on the EIC of alpha 1-antitrypsin, suggesting that peroxides and superoxide anions in smoke contribute to the oxidant capacity of the smoke. The extent of apparent oxidation by a given quantity of smoke condensate increases for as long as an hour from the time the condensate is collected. The addition of hydrogen peroxide to the smoke solution increases both its oxidant content and its ability to inactivate alpha 1-antitrypsin. These data suggest that occurrence of hydrogen peroxide caused by secretion from macrophages found in the small airways of smokers may contribute to a locally damaging environment for alpha 1-antitrypsin in the presence of cigarette smoke that could promote the development of centrilobular emphysema.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979963     DOI: 10.1164/arrd.1982.126.1.25

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  10 in total

1.  Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

Authors:  R C Hubbard; F Ogushi; G A Fells; A M Cantin; S Jallat; M Courtney; R G Crystal
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity.

Authors:  E R Pacht; H Kaseki; J R Mohammed; D G Cornwell; W B Davis
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Cigarette smoke inhibition of ion transport in canine tracheal epithelium.

Authors:  M J Welsh
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

Review 4.  Chronic obstructive pulmonary disease and asthma. General and medical management with special attention to exacerbations.

Authors:  J P Kaajan
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

5.  Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.

Authors:  J I Weitz; E K Silverman; B Thong; E J Campbell
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Inactivation of alpha 1-proteinase inhibitor by Cu(II) and hydrogen peroxide.

Authors:  N S Kwon; P C Chan; L Kesner
Journal:  Agents Actions       Date:  1990-03

7.  Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.

Authors:  F Ogushi; R C Hubbard; C Vogelmeier; G A Fells; R G Crystal
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

8.  Antiproteases modulate bronchial epithelial cell responses to endotoxin.

Authors:  S Koyama; S I Rennard; L Claassen; R A Robbins
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

9.  Free-radical chemistry of cigarette smoke and its toxicological implications.

Authors:  D F Church; W A Pryor
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

10.  Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.

Authors:  Meredith L Sosulski; Katie M Stiles; Esther Z Frenk; Fiona M Hart; Yuki Matsumura; Bishnu P De; Stephen M Kaminsky; Ronald G Crystal
Journal:  JCI Insight       Date:  2020-08-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.